The Safety and Efficacy of Naltrexone and Scopolamine Utilized in the Treatment of Major Depression
Status:
Completed
Trial end date:
2018-11-20
Target enrollment:
Participant gender:
Summary
The purpose of this clinical trial is to determine the safety and efficacy of scopolamine
utilized in conjunction with naltrexone for the treatment of major depression.